"L'histoire se répète", one size does not fit all

Marnix Kuindersma¹, Peter E Spronk^{2

3}

Affiliations

¹ Departments of Intensive Care Medicine, Gelre Hospitals, Albert Schweitzerlaan 31, 7334 DZ, Apeldoorn, The Netherlands. m.kuindersma@gelre.nl.
² Departments of Intensive Care Medicine, Gelre Hospitals, Albert Schweitzerlaan 31, 7334 DZ, Apeldoorn, The Netherlands.
³ Expertise Center for Intensive Care Rehabilitation Apeldoorn (ExpIRA), Albert Schweitzerlaan 31, 7334 DZ, Apeldoorn, The Netherlands.

Comment

Marnix Kuindersma et al. Intensive Care Med. 2021 Oct.

. 2021 Oct;47(10):1169-1170.

doi: 10.1007/s00134-021-06483-2. Epub 2021 Jul 20.

Marnix Kuindersma¹, Peter E Spronk^{2

3}

¹ Departments of Intensive Care Medicine, Gelre Hospitals, Albert Schweitzerlaan 31, 7334 DZ, Apeldoorn, The Netherlands. m.kuindersma@gelre.nl.
² Departments of Intensive Care Medicine, Gelre Hospitals, Albert Schweitzerlaan 31, 7334 DZ, Apeldoorn, The Netherlands.
³ Expertise Center for Intensive Care Rehabilitation Apeldoorn (ExpIRA), Albert Schweitzerlaan 31, 7334 DZ, Apeldoorn, The Netherlands.

No abstract available

Conflict of interest statement

The authors declare that they have no conflict of interest.

"L'histoire se répète", one size does not fit all. Author's reply.
Snow TAC, Saleem N, Singer M, Arulkumaran N. Snow TAC, et al. Intensive Care Med. 2021 Oct;47(10):1171-1172. doi: 10.1007/s00134-021-06497-w. Epub 2021 Aug 6. Intensive Care Med. 2021. PMID: 34363094 Free PMC article. No abstract available.

Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta-regression of randomized-controlled trials.
Snow TAC, Saleem N, Ambler G, Nastouli E, Singer M, Arulkumaran N. Snow TAC, et al. Intensive Care Med. 2021 Jun;47(6):641-652. doi: 10.1007/s00134-021-06416-z. Epub 2021 May 21. Intensive Care Med. 2021. PMID: 34019122 Free PMC article.

1. Snow TAC, Saleem N, Ambler G, Nastouli E, Singer M, Arulkumaran N. Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta-regression of randomized-controlled trials (in eng) Intensive Care Med. 2021;47(6):641–652. doi: 10.1007/s00134-021-06416-z. - DOI - PMC - PubMed
1. Mariette X, et al. Effectiveness of tocilizumab in patients hospitalized with COVID-19: a follow-up of the corimuno-toci-1 randomized clinical trial (in eng) JAMA Intern Med. 2021 doi: 10.1001/jamainternmed.2021.2209. - DOI - PMC - PubMed
1. R. C. Group Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (in eng) Lancet. 2021;397(10285):1637–1645. doi: 10.1016/S0140-6736(21)00676-0. - DOI - PMC - PubMed
1. Matthay MA, et al. Phenotypes and personalized medicine in the acute respiratory distress syndrome (in eng) Intensive Care Med. 2020;46(12):2136–2152. doi: 10.1007/s00134-020-06296-9. - DOI - PMC - PubMed
1. Zhang Y, Chen Y, Meng Z. Immunomodulation for severe COVID-19 pneumonia: the state of the art (in eng) Front Immunol. 2020;11:577442. doi: 10.3389/fimmu.2020.577442. - DOI - PMC - PubMed